Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549

doi:10.16352/j.issn.1001-6325.2022.01.017

Abstract

Abstract: Objective To investigate the effects of eukaryotic elongation factor-2 kinase (eEF2K) gene transfection and sodium tanshinone Ⅱ A sulfonate (STS) on proliferation, invasion and migration of lung adenocarcinoma cell line A549 and its mechanism. Methods The optimal concentration of STS was screened out by preliminary experiment. A549 cells were divided into siRNA-NC group (transfected with siRNA-NC), siRNA-eEF2K group (transfected with siRNA-eEF2K), siRNA-NC+STS group (treated with 10 μg/mL STS after siRNA-NC) and siRNA-eEF2K+STS group (treated with 10 μg/mL STS after siRNA-eEF2K).The survival rate, clone formation, cell counting of transmembrane cells, migration and apoptosis of A549 cells were detected by CCK-8 method, clone formation test, Transwell chamber test, scratch test and flow cytometry. The protein expression levels of protein kinase B (AKT), phosphorylation (p)-AKT, Ki67, matrix metalloproteinase-2 (MMP-2) and B-cell lymphoma-2 genes (Bcl-2) were detected by Western blot. Results Compared with those in siRNA-NC group, the cell survival rate, clone formation rate, number of transmembrane cells, migration rate and p-AKT, Ki67, MMP-2 and Bcl-2 in proteins siRNA-eEF2K+STS group were significantly lower, while the apoptosis rate was significantly higher (P＜0.05). The siRNA-eEF2K+STS group had the largest range of changes in the above indexes. Conclusions Silencing eEF2K combined with STS can synergistically inhibit the proliferation, invasion and migration of A549 cells and promote cell apoptosis. The mechanism is potentially related to the inhibition of protein expression of p-AKT, Ki67, MMP-2 and Bcl-2.

Key words: lung adenocarcinoma, eukaryotic elongation factor 2 kinase, sodium tanshinone ⅡA sulfonate, proliferation, invasion

CLC Number:

R734.2

WANG Bu, YUAN Sheng-fang, ZHANG Chang-hong, YUAN Cheng, HUANG Pan-deng, ZHANG Zhi-hua, ZHAO Jian-qing. Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549[J]. Basic & Clinical Medicine, 2022, 42(1): 106-113.

References

[1]付丹阳, 张捷. 肺腺癌诊断的研究进展[J]. 中国实验诊断学, 2019, 23:172-174.
[2]肖婷, 刘锐, 王明伟. 癌症治疗的新靶点——eEF2K[J]. 生命的化学, 2016, 36:397-403.
[3]Xie J, Shen K, Lenchine RV, et al. Eukaryotic elonga-tion factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis[J]. Int J Cancer, 2018, 142:1865-1877.
[4]杨渊, 陈楠, 马千里, 等. 阿帕替尼联合大剂量丹参酮ⅡA对肺腺癌A549细胞株凋亡及Bim异构体的影响[J]. 现代肿瘤医学, 2019, 27:1319-1323.
[5]王琳, 胡凯文, 迟佳琪, 等. 丹参酮ⅡA磺酸钠联合顺铂对小鼠lewis肺癌细胞上皮性钙黏蛋白表达的影响[J]. 环球中医药, 2018, 11:22-26.
[6]Zhu HC, Song HM, Chen GZ, et al. eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma[J]. Radiother Oncol, 2017, 124:439-447.
[7]张岚, 赵玉倩, 刘博. 新型的eEF2K抑制剂BL-EKI03在乳腺癌中诱导自噬和凋亡作用机制研究[J]. 中国药理学与毒理学杂志, 2016, 30:1063.
[8]Xie J, Liu JH, Liu H, et al. Tanshinone ⅡA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way[J]. BMC Cancer, 2016, 16:1-14.
[9]谢琼, 曾柏荣, 何欣. 丹参酮ⅡA对TP治疗NSCLC临床疗效的影响[J]. 现代肿瘤医学, 2015, 23:341-343.
[10]Liao SY, Kuo IY, Chen YT, et al. AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression[J]. Oncogene, 2019, 38:1-14.
[11]Lu M, Liu B, Xiong H, et al. Trans-3,5,4'-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498[J]. J Cell Mol Med, 2019, 23:2431-2441.
[12]Li H, Zhao J, Jia X, et al. miR-21 promotes growth, invasion and migration of lung cancer cells by AKT/P-AKT/cleaved-caspase 3/MMP-2/MMP-9 signaling pathway[J]. Int J Clin Exp Patho, 2020, 13:692-700.
[13]Karakaᶊ D, Ozpolat B. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target[J]. J Mol Med, 2020, 98:775-787.
[14]肖敏, 王根柱, 戚欣, 等. eEF2K对MDA-MB-231细胞增殖的影响与初步机制研究[J]. 中国药理学通报, 2018, 34:1061-1065.
[15]Wang R, Luo Z, Zhang H, et al. Tanshinone ⅡA reverses gefitinib-resistance in human non-small-cell lung cancer via regulation of VEGFR/Akt pathway[J]. Onco Targets Ther, 2019, 7:9355-9365.